// App-Quantinova.ai

4726 : Inhibitors of histone deacetylase 1 reverse the immune evasion phenotype to enhance T-cell-mediated lysis of prostate and breast carcinoma cells

Researchers

Presenter

  • Sofia R. Gameiro

Principal Investigators

  • Anthony S. Malamas

  • Massimo Fantini

  • Kwong Y. Tsang

  • Soldano Ferrone

  • James W. Hodge

Medical Centers

  • NCI-CCR, Bethesda, MD.

  • Department of Pathology, Massachusetts General Hospital, Boston, MA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

  • Solid malignancies

Biomarkers

  • Cancer antigen 15-3

  • Carcinoembryonic antigen

  • Prostate specific antigen

Drug/Treatment

  • Entinostat

  • Vorinostat

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved